Corrigendum to “Identification and experimental confirmation of novel cGMP efflux inhibitors by virtual ligand screening of vardenafil-analogues” [Biomed. Pharmacother. 126 (2020) 110109]
Farzane Kuresh Kashgari,
Aina Ravna,
Georg Sager,
Roy Lyså,
Istvan Enyedy,
Erik Sveberg Dietrichs
Affiliations
Farzane Kuresh Kashgari
Experimental and Clinical Pharmacology Research Group, Department of Medical Biology, UiT, The Arctic University of Norway, 9037 Tromsø, Norway
Aina Ravna
Experimental and Clinical Pharmacology Research Group, Department of Medical Biology, UiT, The Arctic University of Norway, 9037 Tromsø, Norway
Georg Sager
Experimental and Clinical Pharmacology Research Group, Department of Medical Biology, UiT, The Arctic University of Norway, 9037 Tromsø, Norway; Department of Clinical Pharmacology, Division of Diagnostic Services, University Hospital of North Norway, 9038 Tromsø, Norway
Roy Lyså
Experimental and Clinical Pharmacology Research Group, Department of Medical Biology, UiT, The Arctic University of Norway, 9037 Tromsø, Norway
Istvan Enyedy
Biogen, 115 Broadway, Cambridge, MA 02142, USA
Erik Sveberg Dietrichs
Experimental and Clinical Pharmacology Research Group, Department of Medical Biology, UiT, The Arctic University of Norway, 9037 Tromsø, Norway; Department of Clinical Pharmacology, Division of Diagnostic Services, University Hospital of North Norway, 9038 Tromsø, Norway; Correspondence to: Experimental and Clinical Pharmacology Research Group, The Arctic University of Norway, 9037 Tromsø, Norway.
